id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2006-P-0025-0002,FDA,FDA-2006-P-0025,FDA/DDM to Sanofi-aventis US LLP,Other,ACK-Acknowledgement Letter,2006-12-19T05:00:00Z,2006,12,,,2008-04-11T23:17:24Z,,0,0,0900006480441f21
FDA-2006-P-0025-0001,FDA,FDA-2006-P-0025,FDA/DDM to Sanofi-aventis US LLP,Other,ACK-Acknowledgement Letter,2006-12-19T05:00:00Z,2006,12,,,2008-04-11T23:17:24Z,,0,0,0900006480441ef8